To Be A Local Insider: Boston Scientific Unveils Its China Strategy
This article was originally published in PharmAsia News
Executive Summary
Boston Scientific aims to increase revenue from emerging markets to 15% by 2017 from its current 9%. Executive Vice President Supratim Bose unveiled the ambition during a recent media roundtable and named China as the most important market for the company.